查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1600427

白蛋白市場：按來源、類型、應用程式和最終用戶 - 2025-2030 年全球預測

Albumin Market by Source (Animal Sources, Plant Sources), Type (Non-Recombinant, Recombinant), Application, End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 188 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計2023年白蛋白市值為65.3億美元，預計到2024年將達到69.4億美元，複合年成長率為6.61%，到2030年將達到102.3億美元。

白蛋白市場的範圍和定義植根於其在製藥、診斷和食品行業的多樣化應用。白蛋白是一種從人類血漿中提取的蛋白質，對於維持血液凝固壓力以及在血液中運輸荷爾蒙、藥物和其他物質至關重要。這種需求正在增加，特別是在低蛋白血症的治療、手術和肝臟疾病的治療等醫療環境中，以及在細胞培養基配方的生物技術行業中。最終用途包括醫院、研究機構和診斷實驗室，其中 KEYWORD 在治療和研究應用中的作用至關重要。關鍵的成長要素包括慢性疾病的增加、外科手術的增加以及促進白蛋白生產和配製的生物技術的進步。此外，化妝品和食品業對白蛋白作為穩定劑和乳化劑的需求迅速成長，帶來了潛在的成長機會。公司可以透過投資研發來利用這些機會，開發穩定性和功效更高的基於白蛋白的產品（例如改進的藥物輸送系統）。然而，有關白蛋白使用和生產的嚴格法律規範以及治療藥物的高成本等限制可能會阻礙市場成長。此外，對源自人類血漿的白蛋白的倫理擔憂一直是一個挑戰，推動了對基因工程白蛋白的需求。從創新的角度來看，應專注於開發合成或植物白蛋白替代品以及重組DNA技術的進步，以減少對人類血漿來源的依賴。白蛋白市場的性質是動態的，在不斷的科學進步和不斷成長的醫療保健需求的推動下，預計將出現顯著成長，但必須從戰略上解決監管和道德挑戰。

主要市場統計
基準年[2023] 65.3億美元
預測年份 [2024] 69.4億美元
預測年份 [2030] 102.3億美元
複合年成長率（%） 6.61%

市場動態：揭示快速發展的白蛋白市場的關鍵市場洞察

白蛋白市場正因供需的動態交互作用而轉變。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 慢性病發生率和使用白蛋白作為術後手術部位感染的預測因子。
    • 白蛋白作為食品和化妝品成分的使用迅速增加
  • 市場限制因素
    • 白蛋白可引起感染疾病
  • 市場機會
    • 白蛋白奈米顆粒的持續研究活動
    • 白蛋白生產和精製方法的進展
  • 市場挑戰
    • 白蛋白生產和品管相關的嚴格規定

波特的五力：駕馭白蛋白市場的策略工具

波特的五力架構是了解白蛋白市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解外部對白蛋白市場的影響

外部宏觀環境因素對白蛋白市場表現動態起著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解白蛋白市場的競爭狀況

白蛋白市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位矩陣白蛋白市場供應商績效評估

FPNV 定位矩陣是評估白蛋白市場供應商的重要工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。四個象限清楚且準確地分類供應商，幫助使用者辨識最能滿足其策略目標的合作夥伴和解決方案。

本報告提供了涵蓋關鍵重點領域的全面市場分析：

1. 市場滲透率：對當前市場環境的詳細回顧，包括行業主要企業的大量資料。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 使用白蛋白作為慢性病發生率和術後手術部位感染的預測因子
      • 白蛋白作為食品和化妝品原料的使用正在迅速增加。
    • 抑制因素
      • 白蛋白可能傳染
    • 機會
      • 白蛋白奈米顆粒正在進行的研究活動
      • 白蛋白生產和精製方法的進展
    • 任務
      • 白蛋白生產和品管相關的嚴格規定
  • 市場區隔分析
    • 資料來源：由於某些治療目的的永續性，消費者正在轉向植物來源白蛋白。
    • 類型：加強重組白蛋白作為合成蛋白的研發，推動重組DNA技術
    • 應用：越來越關注疫苗製造和藥物傳輸應用
    • 最終用戶：醫院和血庫白蛋白的廣泛最終用戶
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章白蛋白市場：依來源分類

  • 動物起源
    • 牛血清白蛋白
    • 人血清白蛋白
    • 蛋白白蛋白
  • 植物來源

第7章白蛋白市場：依類型

  • 非重組
  • 重組

第8章白蛋白市場：依應用分類

  • 化妝品原料
  • 文化媒體
  • 藥物輸送
  • 食品配料
  • 治療性的
  • 疫苗成分

第 9 章 白蛋白市場：依最終使用者分類

  • 製藥/生物技術
  • 調查機構

第10章美洲白蛋白市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章 亞太地區白蛋白市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章 歐洲、中東和非洲白蛋白市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • Grifols 完成補償肝硬化患者長期白蛋白（人類用白蛋白注射液）治療的 3 期試驗入組
    • Kedrion 的全球投資組合擴展到中國，提供人力資源
    • GC Biopharma 在巴西簽署 9,000 萬美元血液製品合約
    • Albumedix 與 Cell and Gene Therapy Catapult 簽署合作協議
    • Albumedix 和 Valneva 擴大合作範圍，納入新核准的去活化 COVID-19 疫苗
    • American Regent 推出用於注射混懸液的紫杉醇蛋白結合顆粒（白蛋白結合）
    • SK Plasma 將耗資 2.5 億美元在印尼建造血液製品工廠
    • Grifols 在擴建的都柏林工廠開設新的白蛋白工廠
    • Sartorius 收購 Albumedics：Albumin，一家先進重組治療方法領域的公司
    • Tyvan Biologic Group 獲得 3 億美元融資

公司名單

  • Rockland Immunochemicals Inc.
  • VitroScient
  • Serion GmbH
  • Kraeber & Co. GmbH
  • Promega Corporation
  • Rocky Mountain Biologicals, LLC
  • CENTURION PHARMA Ilac Sanayi ve Ticaret AS
  • Glentham Life Sciences Limited
  • GC Biopharma Corp.
  • Octapharma AG
  • F. Hoffmann-La Roche AG
  • Bio Products Laboratory Ltd.
  • LGC Science Group Holdings Limited
  • Bio-Rad Laboratories, Inc.
  • Biorbyt Ltd.
  • Kedrion SpA
  • Lazuline Biotech Private Limited
  • Boston BioProducts Inc.
  • Bristol-Myers Squibb Company
  • Merck KGaA
  • Agilent Technologies, Inc.
  • Dem Ilac
  • Biogenix Inc. Pvt. Ltd.
  • Biowest SAS
  • SK Plasma
  • CSL Limited
  • Midas Pharma GmbH
  • China Biologic Products Holdings, Inc. by Taibang Biologic Group
  • Aadi Bioscience, Inc.
  • Avantor Inc.
  • Thermo Fisher Scientific Inc.
  • Prospec-Tany Technogene Ltd.
  • Bio-Techne Corporation
  • Becton, Dickinson and Company
  • Atlantis Bioscience Pte Ltd.
  • Baxter International Inc.
  • Akron Biotech
  • InVitria
  • Biophyll GmbH
  • Takeda Pharmaceuticals Company Limited
  • Sartorius AG
  • Grifols SA
  • Ventria Bioscience Inc.
  • InVitroCare Inc.
Product Code: MRR-436901065945

The Albumin Market was valued at USD 6.53 billion in 2023, expected to reach USD 6.94 billion in 2024, and is projected to grow at a CAGR of 6.61%, to USD 10.23 billion by 2030.

The scope and definition of the albumin market are rooted in its diverse applications in pharmaceuticals, diagnostics, and the food industry. Albumin, a protein derived from human plasma, is essential for maintaining oncotic pressure and transporting hormones, drugs, and other substances in the bloodstream. Its necessity is heightened in medical settings, particularly in treating hypoalbuminemia, surgical procedures, and managing liver diseases, as well as in the biotechnology industry for cell culture media formulations. The end-use scope extends to hospitals, research institutes, and diagnostic labs, where albumin's role is critical in therapeutic and research applications. Key growth influencers include the increasing prevalence of chronic diseases, a rise in surgical procedures, and advancements in biotechnology enhancing albumin production and formulation. Additionally, the burgeoning demand for albumin in the cosmetics and food industry as a stabilizing and emulsifying agent presents potential growth opportunities. Companies can capitalize on these opportunities by investing in research to develop albumin-based products with enhanced stability and effectiveness, such as improved drug delivery systems. However, the market faces limitations like stringent regulatory frameworks governing albumin use and production, and the high cost of therapies, which can be barriers to market growth. Moreover, ethical concerns over albumin sourced from human plasma pose challenges, pushing the demand for recombinant albumin solutions. In terms of innovation, emphasis should be placed on developing synthetic or plant-based albumin alternatives and advancing recombinant DNA technology to decrease reliance on human plasma sources. The nature of the albumin market is dynamic, driven by continual scientific advancements and increasing healthcare demands, positioning it for substantial growth but necessitating strategic navigation of regulatory and ethical challenges.

KEY MARKET STATISTICS
Base Year [2023] USD 6.53 billion
Estimated Year [2024] USD 6.94 billion
Forecast Year [2030] USD 10.23 billion
CAGR (%) 6.61%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Albumin Market

The Albumin Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Incidence of chronic diseases and use of albumin as a predictor of postoperative surgical site infections
    • Surging utilization of albumin as a food and cosmetic ingredient
  • Market Restraints
    • Potential of albumin to cause transmission of infections
  • Market Opportunities
    • Ongoing research activities regarding albumin nanoparticles
    • Advancements in albumin production and purification methods
  • Market Challenges
    • Stringent regulations associated with albumin manufacturing and quality control

Porter's Five Forces: A Strategic Tool for Navigating the Albumin Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Albumin Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Albumin Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Albumin Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Albumin Market

A detailed market share analysis in the Albumin Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Albumin Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Albumin Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Key Company Profiles

The report delves into recent significant developments in the Albumin Market, highlighting leading vendors and their innovative profiles. These include Rockland Immunochemicals Inc., VitroScient, Serion GmbH, Kraeber & Co. GmbH, Promega Corporation, Rocky Mountain Biologicals, LLC, CENTURION PHARMA Ilac Sanayi ve Ticaret A.S., Glentham Life Sciences Limited, GC Biopharma Corp., Octapharma AG, F. Hoffmann-La Roche AG, Bio Products Laboratory Ltd., LGC Science Group Holdings Limited, Bio-Rad Laboratories, Inc., Biorbyt Ltd., Kedrion S.p.A, Lazuline Biotech Private Limited, Boston BioProducts Inc., Bristol-Myers Squibb Company, Merck KGaA, Agilent Technologies, Inc., Dem Ilac, Biogenix Inc. Pvt. Ltd., Biowest SAS, SK Plasma, CSL Limited, Midas Pharma GmbH, China Biologic Products Holdings, Inc. by Taibang Biologic Group, Aadi Bioscience, Inc., Avantor Inc., Thermo Fisher Scientific Inc., Prospec-Tany Technogene Ltd., Bio-Techne Corporation, Becton, Dickinson and Company, Atlantis Bioscience Pte Ltd., Baxter International Inc., Akron Biotech, InVitria, Biophyll GmbH, Takeda Pharmaceuticals Company Limited, Sartorius AG, Grifols SA, Ventria Bioscience Inc., and InVitroCare Inc..

Market Segmentation & Coverage

This research report categorizes the Albumin Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Source, market is studied across Animal Sources and Plant Sources. The Animal Sources is further studied across Bovine Serum Albumin, Human Serum Albumin, and Ovalbumin.
  • Based on Type, market is studied across Non-Recombinant and Recombinant.
  • Based on Application, market is studied across Cosmetic Ingredient, Culture Media, Drug Delivery, Food Ingredient, Therapeutic, and Vaccine Ingredient.
  • Based on End User, market is studied across Pharmaceutical & Biotechnology and Research Institutes.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Incidence of chronic diseases and use of albumin as a predictor of postoperative surgical site infections
      • 5.1.1.2. Surging utilization of albumin as a food and cosmetic ingredient
    • 5.1.2. Restraints
      • 5.1.2.1. Potential of albumin to cause transmission of infections
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing research activities regarding albumin nanoparticles
      • 5.1.3.2. Advancements in albumin production and purification methods
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent regulations associated with albumin manufacturing and quality control
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Source: Consumer shift toward the plant-based albumins due to enhanced sustainability for specific therapeutic purposes.
    • 5.2.2. Type: Enhanced emphasis on the research and development of recombinant albumin as a synthetic protein to promote recombinant DNA technology
    • 5.2.3. Application: Rising focus on vaccine manufacturing and drug delivery applications
    • 5.2.4. End-User: Extensive end-users of the albumin in hospitals and blood banks
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Albumin Market, by Source

  • 6.1. Introduction
  • 6.2. Animal Sources
    • 6.2.1. Bovine Serum Albumin
    • 6.2.2. Human Serum Albumin
    • 6.2.3. Ovalbumin
  • 6.3. Plant Sources

7. Albumin Market, by Type

  • 7.1. Introduction
  • 7.2. Non-Recombinant
  • 7.3. Recombinant

8. Albumin Market, by Application

  • 8.1. Introduction
  • 8.2. Cosmetic Ingredient
  • 8.3. Culture Media
  • 8.4. Drug Delivery
  • 8.5. Food Ingredient
  • 8.6. Therapeutic
  • 8.7. Vaccine Ingredient

9. Albumin Market, by End User

  • 9.1. Introduction
  • 9.2. Pharmaceutical & Biotechnology
  • 9.3. Research Institutes

10. Americas Albumin Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Albumin Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Albumin Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Grifols Completes Enrollment In Phase 3 Study Of Long-Term Albutein (Albumin-Human Injection) Therapy For Patients With Decompensated Cirrhosis
    • 13.3.2. Kedrion's Global Portfolio Expands To China To Supply Human Albumin
    • 13.3.3. GC Biopharma inks USD 90mn deal for blood products in Brazil
    • 13.3.4. Albumedix Enters into Collaboration Agreement with Cell and Gene Therapy Catapult
    • 13.3.5. Albumedix and Valneva expand collaboration to include newly approved inactivated COVID-19 vaccine
    • 13.3.6. American Regent Launches Paclitaxel Protein-Bound Particles for Injectable Suspension (Albumin-Bound)
    • 13.3.7. SK Plasma to build USD 250m blood products plant in Indonesia
    • 13.3.8. Grifols Inaugurates New Albumin Plant At its Expanding Dublin Site
    • 13.3.9. Sartorius acquires Albumedix: A player in advanced therapies based on recombinant albumin
    • 13.3.10. Taibang Biologic Group Secures Equity Raising of USD 300 Million

Companies Mentioned

  • 1. Rockland Immunochemicals Inc.
  • 2. VitroScient
  • 3. Serion GmbH
  • 4. Kraeber & Co. GmbH
  • 5. Promega Corporation
  • 6. Rocky Mountain Biologicals, LLC
  • 7. CENTURION PHARMA Ilac Sanayi ve Ticaret A.S.
  • 8. Glentham Life Sciences Limited
  • 9. GC Biopharma Corp.
  • 10. Octapharma AG
  • 11. F. Hoffmann-La Roche AG
  • 12. Bio Products Laboratory Ltd.
  • 13. LGC Science Group Holdings Limited
  • 14. Bio-Rad Laboratories, Inc.
  • 15. Biorbyt Ltd.
  • 16. Kedrion S.p.A
  • 17. Lazuline Biotech Private Limited
  • 18. Boston BioProducts Inc.
  • 19. Bristol-Myers Squibb Company
  • 20. Merck KGaA
  • 21. Agilent Technologies, Inc.
  • 22. Dem Ilac
  • 23. Biogenix Inc. Pvt. Ltd.
  • 24. Biowest SAS
  • 25. SK Plasma
  • 26. CSL Limited
  • 27. Midas Pharma GmbH
  • 28. China Biologic Products Holdings, Inc. by Taibang Biologic Group
  • 29. Aadi Bioscience, Inc.
  • 30. Avantor Inc.
  • 31. Thermo Fisher Scientific Inc.
  • 32. Prospec-Tany Technogene Ltd.
  • 33. Bio-Techne Corporation
  • 34. Becton, Dickinson and Company
  • 35. Atlantis Bioscience Pte Ltd.
  • 36. Baxter International Inc.
  • 37. Akron Biotech
  • 38. InVitria
  • 39. Biophyll GmbH
  • 40. Takeda Pharmaceuticals Company Limited
  • 41. Sartorius AG
  • 42. Grifols SA
  • 43. Ventria Bioscience Inc.
  • 44. InVitroCare Inc.

LIST OF FIGURES

  • FIGURE 1. ALBUMIN MARKET RESEARCH PROCESS
  • FIGURE 2. ALBUMIN MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL ALBUMIN MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL ALBUMIN MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL ALBUMIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL ALBUMIN MARKET SIZE, BY SOURCE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL ALBUMIN MARKET SIZE, BY SOURCE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL ALBUMIN MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL ALBUMIN MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL ALBUMIN MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL ALBUMIN MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL ALBUMIN MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL ALBUMIN MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS ALBUMIN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS ALBUMIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES ALBUMIN MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES ALBUMIN MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC ALBUMIN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC ALBUMIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ALBUMIN MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA ALBUMIN MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. ALBUMIN MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. ALBUMIN MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. ALBUMIN MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL ALBUMIN MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ALBUMIN MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL ALBUMIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. ALBUMIN MARKET DYNAMICS
  • TABLE 7. GLOBAL ALBUMIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL ALBUMIN MARKET SIZE, BY BOVINE SERUM ALBUMIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL ALBUMIN MARKET SIZE, BY HUMAN SERUM ALBUMIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL ALBUMIN MARKET SIZE, BY OVALBUMIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL ALBUMIN MARKET SIZE, BY PLANT SOURCES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL ALBUMIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL ALBUMIN MARKET SIZE, BY NON-RECOMBINANT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL ALBUMIN MARKET SIZE, BY RECOMBINANT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL ALBUMIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL ALBUMIN MARKET SIZE, BY COSMETIC INGREDIENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL ALBUMIN MARKET SIZE, BY CULTURE MEDIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL ALBUMIN MARKET SIZE, BY DRUG DELIVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL ALBUMIN MARKET SIZE, BY FOOD INGREDIENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL ALBUMIN MARKET SIZE, BY THERAPEUTIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL ALBUMIN MARKET SIZE, BY VACCINE INGREDIENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL ALBUMIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL ALBUMIN MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL ALBUMIN MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS ALBUMIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS ALBUMIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS ALBUMIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS ALBUMIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS ALBUMIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA ALBUMIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA ALBUMIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA ALBUMIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA ALBUMIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL ALBUMIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL ALBUMIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL ALBUMIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL ALBUMIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA ALBUMIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA ALBUMIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA ALBUMIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA ALBUMIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 48. MEXICO ALBUMIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 49. MEXICO ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO ALBUMIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. MEXICO ALBUMIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. MEXICO ALBUMIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES ALBUMIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES ALBUMIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES ALBUMIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES ALBUMIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 58. UNITED STATES ALBUMIN MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 59. ASIA-PACIFIC ALBUMIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC ALBUMIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC ALBUMIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC ALBUMIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 64. ASIA-PACIFIC ALBUMIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 65. AUSTRALIA ALBUMIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 66. AUSTRALIA ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2018-2030 (USD MILLION)
  • TABLE 67. AUSTRALIA ALBUMIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. AUSTRALIA ALBUMIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. AUSTRALIA ALBUMIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 70. CHINA ALBUMIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 71. CHINA ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2018-2030 (USD MILLION)
  • TABLE 72. CHINA ALBUMIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. CHINA ALBUMIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. CHINA ALBUMIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 75. INDIA ALBUMIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 76. INDIA ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2018-2030 (USD MILLION)
  • TABLE 77. INDIA ALBUMIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. INDIA ALBUMIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. INDIA ALBUMIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 80. INDONESIA ALBUMIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 81. INDONESIA ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2018-2030 (USD MILLION)
  • TABLE 82. INDONESIA ALBUMIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. INDONESIA ALBUMIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. INDONESIA ALBUMIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 85. JAPAN ALBUMIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 86. JAPAN ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2018-2030 (USD MILLION)
  • TABLE 87. JAPAN ALBUMIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. JAPAN ALBUMIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. JAPAN ALBUMIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 90. MALAYSIA ALBUMIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 91. MALAYSIA ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2018-2030 (USD MILLION)
  • TABLE 92. MALAYSIA ALBUMIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. MALAYSIA ALBUMIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. MALAYSIA ALBUMIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 95. PHILIPPINES ALBUMIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 96. PHILIPPINES ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2018-2030 (USD MILLION)
  • TABLE 97. PHILIPPINES ALBUMIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. PHILIPPINES ALBUMIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. PHILIPPINES ALBUMIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 100. SINGAPORE ALBUMIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 101. SINGAPORE ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2018-2030 (USD MILLION)
  • TABLE 102. SINGAPORE ALBUMIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. SINGAPORE ALBUMIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 104. SINGAPORE ALBUMIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 105. SOUTH KOREA ALBUMIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 106. SOUTH KOREA ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2018-2030 (USD MILLION)
  • TABLE 107. SOUTH KOREA ALBUMIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. SOUTH KOREA ALBUMIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 109. SOUTH KOREA ALBUMIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 110. TAIWAN ALBUMIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 111. TAIWAN ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2018-2030 (USD MILLION)
  • TABLE 112. TAIWAN ALBUMIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. TAIWAN ALBUMIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. TAIWAN ALBUMIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 115. THAILAND ALBUMIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 116. THAILAND ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2018-2030 (USD MILLION)
  • TABLE 117. THAILAND ALBUMIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. THAILAND ALBUMIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. THAILAND ALBUMIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 120. VIETNAM ALBUMIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 121. VIETNAM ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2018-2030 (USD MILLION)
  • TABLE 122. VIETNAM ALBUMIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. VIETNAM ALBUMIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 124. VIETNAM ALBUMIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA ALBUMIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA ALBUMIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA ALBUMIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA ALBUMIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA ALBUMIN MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 131. DENMARK ALBUMIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 132. DENMARK ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2018-2030 (USD MILLION)
  • TABLE 133. DENMARK ALBUMIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. DENMARK ALBUMIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. DENMARK ALBUMIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 136. EGYPT ALBUMIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 137. EGYPT ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2018-2030 (USD MILLION)
  • TABLE 138. EGYPT ALBUMIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. EGYPT ALBUMIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 140. EGYPT ALBUMIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 141. FINLAND ALBUMIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 142. FINLAND ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2018-2030 (USD MILLION)
  • TABLE 143. FINLAND ALBUMIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. FINLAND ALBUMIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 145. FINLAND ALBUMIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 146. FRANCE ALBUMIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 147. FRANCE ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2018-2030 (USD MILLION)
  • TABLE 148. FRANCE ALBUMIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 149. FRANCE ALBUMIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 150. FRANCE ALBUMIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 151. GERMANY ALBUMIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 152. GERMANY ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2018-2030 (USD MILLION)
  • TABLE 153. GERMANY ALBUMIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 154. GERMANY ALBUMIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 155. GERMANY ALBUMIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 156. ISRAEL ALBUMIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 157. ISRAEL ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2018-2030 (USD MILLION)
  • TABLE 158. ISRAEL ALBUMIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 159. ISRAEL ALBUMIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 160. ISRAEL ALBUMIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 161. ITALY ALBUMIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 162. ITALY ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2018-2030 (USD MILLION)
  • TABLE 163. ITALY ALBUMIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 164. ITALY ALBUMIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 165. ITALY ALBUMIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 166. NETHERLANDS ALBUMIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 167. NETHERLANDS ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2018-2030 (USD MILLION)
  • TABLE 168. NETHERLANDS ALBUMIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 169. NETHERLANDS ALBUMIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 170. NETHERLANDS ALBUMIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 171. NIGERIA ALBUMIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 172. NIGERIA ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2018-2030 (USD MILLION)
  • TABLE 173. NIGERIA ALBUMIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 174. NIGERIA ALBUMIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 175. NIGERIA ALBUMIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 176. NORWAY ALBUMIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 177. NORWAY ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2018-2030 (USD MILLION)
  • TABLE 178. NORWAY ALBUMIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 179. NORWAY ALBUMIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 180. NORWAY ALBUMIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 181. POLAND ALBUMIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 182. POLAND ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2018-2030 (USD MILLION)
  • TABLE 183. POLAND ALBUMIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 184. POLAND ALBUMIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 185. POLAND ALBUMIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 186. QATAR ALBUMIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 187. QATAR ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2018-2030 (USD MILLION)
  • TABLE 188. QATAR ALBUMIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 189. QATAR ALBUMIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 190. QATAR ALBUMIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 191. RUSSIA ALBUMIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 192. RUSSIA ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2018-2030 (USD MILLION)
  • TABLE 193. RUSSIA ALBUMIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 194. RUSSIA ALBUMIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 195. RUSSIA ALBUMIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 196. SAUDI ARABIA ALBUMIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 197. SAUDI ARABIA ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2018-2030 (USD MILLION)
  • TABLE 198. SAUDI ARABIA ALBUMIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 199. SAUDI ARABIA ALBUMIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 200. SAUDI ARABIA ALBUMIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 201. SOUTH AFRICA ALBUMIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 202. SOUTH AFRICA ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH AFRICA ALBUMIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 204. SOUTH AFRICA ALBUMIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 205. SOUTH AFRICA ALBUMIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 206. SPAIN ALBUMIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 207. SPAIN ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2018-2030 (USD MILLION)
  • TABLE 208. SPAIN ALBUMIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 209. SPAIN ALBUMIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 210. SPAIN ALBUMIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 211. SWEDEN ALBUMIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 212. SWEDEN ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2018-2030 (USD MILLION)
  • TABLE 213. SWEDEN ALBUMIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 214. SWEDEN ALBUMIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 215. SWEDEN ALBUMIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 216. SWITZERLAND ALBUMIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 217. SWITZERLAND ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2018-2030 (USD MILLION)
  • TABLE 218. SWITZERLAND ALBUMIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 219. SWITZERLAND ALBUMIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 220. SWITZERLAND ALBUMIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 221. TURKEY ALBUMIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 222. TURKEY ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2018-2030 (USD MILLION)
  • TABLE 223. TURKEY ALBUMIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 224. TURKEY ALBUMIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 225. TURKEY ALBUMIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 226. UNITED ARAB EMIRATES ALBUMIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 227. UNITED ARAB EMIRATES ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED ARAB EMIRATES ALBUMIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED ARAB EMIRATES ALBUMIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED ARAB EMIRATES ALBUMIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED KINGDOM ALBUMIN MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED KINGDOM ALBUMIN MARKET SIZE, BY ANIMAL SOURCES, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED KINGDOM ALBUMIN MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED KINGDOM ALBUMIN MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 235. UNITED KINGDOM ALBUMIN MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 236. ALBUMIN MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 237. ALBUMIN MARKET, FPNV POSITIONING MATRIX, 2023